Antiphospholipid Antibodies and Thrombotic Events in COVID-19 Patients Hospitalized in Medicine Ward - Immunologie-Immunopathologie-Immunothérapie Accéder directement au contenu
Poster De Conférence Année : 2020

Antiphospholipid Antibodies and Thrombotic Events in COVID-19 Patients Hospitalized in Medicine Ward

Corinne Frère
  • Fonction : Auteur
  • PersonId : 1078779
Paul Gougis
  • Fonction : Auteur
  • PersonId : 1054190

Résumé

This is a prospective single-center observational cohort study of COVID-19 patients admitted in the Internal Medicine and Clinical Immunology Department of a tertiary care university hospital (Paris, France). Included patients were older than 18 years with an initial requirement for hospitalization in a medical ward and a positive SARS-CoV-2 RT-PCR assay from nasal swabs. Patients were tested for the presence of aPL antibodies. Limit of positivity was fixed at 15 and 10 units/mL (99th percentile of a control population) for aCL and aβ2GPI antibodies respectively. Continuous variables are presented as median (interquartile range, IQR) and were compared using Wilcoxon’s- test. Categorical variables are presented as count (percent) and were compared using Fisher’s-test.
Fichier principal
Vignette du fichier
main.pdf (372.08 Ko) Télécharger le fichier

Dates et versions

hal-03831591 , version 1 (02-11-2022)

Licence

Copyright (Tous droits réservés)

Identifiants

Citer

Alexandre Le Joncour, Corinne Frère, Isabelle Martin-Toutain, Paul Gougis, Pascale Ghillani-Dalbin, et al.. Antiphospholipid Antibodies and Thrombotic Events in COVID-19 Patients Hospitalized in Medicine Ward. ACR Convergence 2020, Nov 2020, Online, United States. , 20 (2), pp.102729, 2021, Elsevier Public Health Emergency Collection. ⟨10.1016/j.autrev.2020.102729⟩. ⟨hal-03831591⟩
24 Consultations
27 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More